RecruitingNCT07065747

Quantification & Classification of Inflammatory Cells in Uveitis Using OCT

Objective Grading of Intraocular Inflammation in Uveitis Using Optical Coherence Tomography


Sponsor

Oregon Health and Science University

Enrollment

125 participants

Start Date

Sep 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this study is to determine if it's possible to use a high resolution imaging device called optical coherence tomography (OCT) to develop an unbiased, standard method of counting and categorizing the various types of cells and proteins found in an eye condition called anterior uveitis. Anterior uveitis is a type of inflammation in the eye that can be caused by many different diseases of the body.


Eligibility

Min Age: 5 YearsMax Age: 85 Years

Inclusion Criteria3

  • Uveitis Group: Eyes with active intraocular inflammation and a clinical diagnose of spondyloarthritis/HLA-B27 associated anterior uveitis, Juvenile Idiopathic Arthritis (JIA) associated chronic anterior uveitis, Herpes Simplex Virus (HSV) anterior uveitis, Birdshot chorioretinitis, Behcet disease uveitis, sarcoidosis associated uveitis, uveitis of any additional type, or uveitis masquerade.
  • Posterior Vitreous Detachment Group: Eyes with vitreous floaters and posterior vitreous detachment (PVD).
  • Healthy/Control Group: Healthy eyes with no history of uveitis, PVD, or previous eye surgery.

Exclusion Criteria4

  • Inability to give informed consent.
  • Inability to maintain stable fixation for OCT imaging.
  • Inability to commit to required visits to complete the study.
  • Pregnancy and breastfeeding.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Casey Eye Institute - Oregon Health & Science University

Portland, Oregon, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07065747


Related Trials